STOCK TITAN

NOTICE TO DISREGARD -- Avicanna Inc.

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Avicanna Inc. has issued a correction regarding its previous news release concerning its presentation at the Q1 Virtual Investor Summit. The initial release was dated March 11, 2021, and has now been rendered void. Journalists and readers are advised to disregard it, ensuring that investors and stakeholders have accurate and reliable information regarding the company's activities.

Positive
  • None.
Negative
  • None.

TORONTO, March 15, 2021 (GLOBE NEWSWIRE) -- We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor Summit” issued March 11, 2021, over GlobeNewswire.


FAQ

What was the correction made by Avicanna on March 15, 2021?

Avicanna advised that the news release about its presentation at the Q1 Virtual Investor Summit issued on March 11, 2021, should be disregarded.

Why should investors disregard the March 11 news release from Avicanna?

The March 11 news release has been officially voided, and ignoring it ensures that investors are not misled by outdated or inaccurate information.

What is the significance of Avicanna's announcement on March 15, 2021?

The announcement clarifies prior misinformation and underscores the company's commitment to providing accurate information to its investors.

AVICANNA INC

OTC:AVCNF

AVCNF Rankings

AVCNF Latest News

AVCNF Stock Data

18.41M
38.34M
23.22%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto